Adverse events are rare after single-dose montelukast exposures in children - Arnold DH, Bowman N, Reiss TF, Hartert TV, Seger DL.

STUDY OBJECTIVE: Montelukast sodium is a leukotriene-receptor antagonist approved as a controller medication for chronic asthma and allergic rhinitis in children and adults. We sought to characterize adverse events associated with single montelukast exposu...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news